Clinical Trial Update: A Study of Apatinib Combined With Temozolomide in Patients Witn Advanced Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial investigating apatinib in combination with temozolomide for advanced melanoma is underway with an update on study status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Apatinib (apatinib)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Advanced Melanoma | Phase 2 | Status: UNKNOWN